Since the start of the pandemic, over 15 million youth have tested positive for COVID-19 (American Academy of Pediatrics [AAP], 2023), but less is known about the impact of COVID-19 in children compared to adults. While children generally experience fewer and less severe acute symptoms, a subgroup of children may become quite ill with COVID-19 or multisystem inflammatory syndrome in children (MIS-C). Like adults, a minority of children also go on to develop what is now known as “pediatric long COVID”. Research in children with COVID-19 is limited, but emerging studies suggest that, like adults, children with more severe or persisting forms of COVID-19, including long COVID, may be at risk for a range of physical, cognitive, and emotional/behavioral symptoms. Pediatric neuropsychologists are uniquely positioned to assess neurocognitive functioning in children with COVID-19, help children and families understand the factors affecting the child’s functioning, and provide recommendations for appropriate interventions and management at home, at school, and in the community.